N-[(2S)-1-[[(1S)-1-(2,3,3a,4,5,6,7,7a-octahydro-1H-benzimidazol-2-yl)ethyl]amino]-4-[(2R)-2-cyclohexylpyrrolidin-1-yl]-1,4-dioxobutan-2-yl]-4,4-dimethylpentanamide

C30H53N5O3 — CID 155622260

IUPACN-[(2S)-1-[[(1S)-1-(2,3,3a,4,5,6,7,7a-octahydro-1H-benzimidazol-2-yl)ethyl]amino]-4-[(2R)-2-cyclohexylpyrrolidin-1-yl]-1,4-dioxobutan-2-yl]-4,4-dimethylpentanamide
SMILESC[C@H](NC(=O)[C@H](CC(=O)N1CCC[C@@H]1C1CCCCC1)NC(=O)CCC(C)(C)C)C1NC2CCCCC2N1
InChIInChI=1S/C30H53N5O3/c1-20(28-33-22-13-8-9-14-23(22)34-28)31-29(38)24(32-26(36)16-17-30(2,3)4)19-27(37)35-18-10-15-25(35)21-11-6-5-7-12-21/h20-25,28,33-34H,5-19H2,1-4H3,(H,31,38)(H,32,36)/t20-,22?,23?,24-,25+,28?/m0/s1
InChIKeyVLIBRKHFCNRALK-BYPCNJGLSA-N
MW531.79 g/mol
LogP3.59
Rot. Bonds9

About N-[(2S)-1-[[(1S)-1-(2,3,3a,4,5,6,7,7a-octahydro-1H-benzimidazol-2-yl)ethyl]amino]-4-[(2R)-2-cyclohexylpyrrolidin-1-yl]-1,4-dioxobutan-2-yl]-4,4-dimethylpentanamide

N-[(2S)-1-[[(1S)-1-(2,3,3a,4,5,6,7,7a-octahydro-1H-benzimidazol-2-yl)ethyl]amino]-4-[(2R)-2-cyclohexylpyrrolidin-1-yl]-1,4-dioxobutan-2-yl]-4,4-dimethylpentanamide (PubChem CID 155622260) has the molecular formula C30H53N5O3 and a molecular weight of 531.79 g/mol. Its IUPAC name is N-[(2S)-1-[[(1S)-1-(2,3,3a,4,5,6,7,7a-octahydro-1H-benzimidazol-2-yl)ethyl]amino]-4-[(2R)-2-cyclohexylpyrrolidin-1-yl]-1,4-dioxobutan-2-yl]-4,4-dimethylpentanamide.

Molecular Properties

Compound NameN-[(2S)-1-[[(1S)-1-(2,3,3a,4,5,6,7,7a-octahydro-1H-benzimidazol-2-yl)ethyl]amino]-4-[(2R)-2-cyclohexylpyrrolidin-1-yl]-1,4-dioxobutan-2-yl]-4,4-dimethylpentanamide
PubChem CID155622260
Molecular FormulaC30H53N5O3
Molecular Weight531.79 g/mol
Exact Mass531.41
IUPAC NameN-[(2S)-1-[[(1S)-1-(2,3,3a,4,5,6,7,7a-octahydro-1H-benzimidazol-2-yl)ethyl]amino]-4-[(2R)-2-cyclohexylpyrrolidin-1-yl]-1,4-dioxobutan-2-yl]-4,4-dimethylpentanamide
SMILESC[C@H](NC(=O)[C@H](CC(=O)N1CCC[C@@H]1C1CCCCC1)NC(=O)CCC(C)(C)C)C1NC2CCCCC2N1
InChIInChI=1S/C30H53N5O3/c1-20(28-33-22-13-8-9-14-23(22)34-28)31-29(38)24(32-26(36)16-17-30(2,3)4)19-27(37)35-18-10-15-25(35)21-11-6-5-7-12-21/h20-25,28,33-34H,5-19H2,1-4H3,(H,31,38)(H,32,36)/t20-,22?,23?,24-,25+,28?/m0/s1
InChIKeyVLIBRKHFCNRALK-BYPCNJGLSA-N
XLogP3.59
TPSA102.57 Ų
H-Bond Donors4
H-Bond Acceptors5
Rotatable Bonds9
Heavy Atoms38
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500531.79
LogP ≤ 53.59
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 105

Analyze N-[(2S)-1-[[(1S)-1-(2,3,3a,4,5,6,7,7a-octahydro-1H-benzimidazol-2-yl)ethyl]amino]-4-[(2R)-2-cyclohexylpyrrolidin-1-yl]-1,4-dioxobutan-2-yl]-4,4-dimethylpentanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[(2S)-1-[[(1S)-1-(2,3,3a,4,5,6,7,7a-octahydro-1H-benzimidazol-2-yl)ethyl]amino]-4-[(2R)-2-cyclohexylpyrrolidin-1-yl]-1,4-dioxobutan-2-yl]-4,4-dimethylpentanamide?
The IUPAC name of N-[(2S)-1-[[(1S)-1-(2,3,3a,4,5,6,7,7a-octahydro-1H-benzimidazol-2-yl)ethyl]amino]-4-[(2R)-2-cyclohexylpyrrolidin-1-yl]-1,4-dioxobutan-2-yl]-4,4-dimethylpentanamide (CID 155622260) is N-[(2S)-1-[[(1S)-1-(2,3,3a,4,5,6,7,7a-octahydro-1H-benzimidazol-2-yl)ethyl]amino]-4-[(2R)-2-cyclohexylpyrrolidin-1-yl]-1,4-dioxobutan-2-yl]-4,4-dimethylpentanamide.
What is the SMILES notation for N-[(2S)-1-[[(1S)-1-(2,3,3a,4,5,6,7,7a-octahydro-1H-benzimidazol-2-yl)ethyl]amino]-4-[(2R)-2-cyclohexylpyrrolidin-1-yl]-1,4-dioxobutan-2-yl]-4,4-dimethylpentanamide?
The canonical SMILES for N-[(2S)-1-[[(1S)-1-(2,3,3a,4,5,6,7,7a-octahydro-1H-benzimidazol-2-yl)ethyl]amino]-4-[(2R)-2-cyclohexylpyrrolidin-1-yl]-1,4-dioxobutan-2-yl]-4,4-dimethylpentanamide is C[C@H](NC(=O)[C@H](CC(=O)N1CCC[C@@H]1C1CCCCC1)NC(=O)CCC(C)(C)C)C1NC2CCCCC2N1.
What is the InChIKey of N-[(2S)-1-[[(1S)-1-(2,3,3a,4,5,6,7,7a-octahydro-1H-benzimidazol-2-yl)ethyl]amino]-4-[(2R)-2-cyclohexylpyrrolidin-1-yl]-1,4-dioxobutan-2-yl]-4,4-dimethylpentanamide?
The InChIKey is VLIBRKHFCNRALK-BYPCNJGLSA-N. The full InChI is InChI=1S/C30H53N5O3/c1-20(28-33-22-13-8-9-14-23(22)34-28)31-29(38)24(32-26(36)16-17-30(2,3)4)19-27(37)35-18-10-15-25(35)21-11-6-5-7-12-21/h20-25,28,33-34H,5-19H2,1-4H3,(H,31,38)(H,32,36)/t20-,22?,23?,24-,25+,28?/m0/s1.
What are the key properties of N-[(2S)-1-[[(1S)-1-(2,3,3a,4,5,6,7,7a-octahydro-1H-benzimidazol-2-yl)ethyl]amino]-4-[(2R)-2-cyclohexylpyrrolidin-1-yl]-1,4-dioxobutan-2-yl]-4,4-dimethylpentanamide?
N-[(2S)-1-[[(1S)-1-(2,3,3a,4,5,6,7,7a-octahydro-1H-benzimidazol-2-yl)ethyl]amino]-4-[(2R)-2-cyclohexylpyrrolidin-1-yl]-1,4-dioxobutan-2-yl]-4,4-dimethylpentanamide has a molecular weight of 531.79 g/mol, XLogP of 3.59, 9 rotatable bonds, 4 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(2S)-1-[[(1S)-1-(2,3,3a,4,5,6,7,7a-octahydro-1H-benzimidazol-2-yl)ethyl]amino]-4-[(2R)-2-cyclohexylpyrrolidin-1-yl]-1,4-dioxobutan-2-yl]-4,4-dimethylpentanamide is sourced from PubChem (CID 155622260), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).